In a separate study, an implant containing a different investigational endothelin antagonist (PER-001) reduced macular ...

Trump gave the companies 60 days to voluntarily comply, threatening to "deploy every tool in our arsenal to protect American ...

President Donald Trump is ratcheting up the pressure on major drugmakers to bring their US prices in line with the far lower ...

President Donald Trump sent letters to 17 pharmaceutical CEOs demanding lower drug prices within 60 days, following an ...

A fresh ultimatum demanding "binding commitments" to lower U.S. drug prices sent pharma firms scrambling Friday.

Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $2.38 per share dividend for the third quarter of 2025. The dividend will be paid on September 12, 2025, to all stockholders ...

On July 24, 2025, the PTO Acting Director Coke Morgan Stewart discretionarily denied Amgen’s IPR2025-00601 and IPR2025-00602 challenging ...

With two molecules in mid-stage trials, the pharma giant is taking another swing at the difficult disease with a greater ...

Regeneron Pharmaceuticals delivered strong Q2 results and made net progress with its commercial portfolio and pipeline. Click ...

President Donald Trump sent letters to more than a dozen major drugmakers Thursday demanding that they lower the cost of ...

President Trump sent letters Thursday to 17 of the world’s largest drug companies, telling them to take more steps to slash ...

Experts are skeptical that Big Pharma companies will cut prices after President Donald Trump demands Most Favored Nation policies within 60 days.